Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001350119 | SCV001544497 | uncertain significance | Developmental and epileptic encephalopathy, 36 | 2024-01-29 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 5 of the ALG13 gene. It does not directly change the encoded amino acid sequence of the ALG13 protein. It affects a nucleotide within the consensus splice site. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ALG13-related conditions. ClinVar contains an entry for this variant (Variation ID: 1045671). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001751685 | SCV001986594 | uncertain significance | not provided | 2019-08-12 | criteria provided, single submitter | clinical testing | In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV001751685 | SCV002568191 | uncertain significance | not provided | 2022-06-08 | criteria provided, single submitter | clinical testing | PM2 |
Fulgent Genetics, |
RCV001350119 | SCV002790162 | uncertain significance | Developmental and epileptic encephalopathy, 36 | 2021-11-27 | criteria provided, single submitter | clinical testing |